Renibacterium salmoninarum (BKD): Etiology, Pathogenesis, Diagnostics, and Control
Introduction
Bacterial kidney disease (BKD) is a chronic, systemic infection of salmonid fish caused by the Gram-positive intracellular bacterium Renibacterium salmoninarum [1]. The disease represents a major constraint to salmonid aquaculture and wild stock conservation worldwide, causing significant mortality and economic losses in both freshwater and marine production stages [2, 3]. R. salmoninarum is a slow-growing, fastidious organism that primarily targets the kidney and other hematopoietic tissues, leading to granulomatous inflammation and progressive organ failure [4]. This article provides a detailed academic reference on the bacterium, its virulence mechanisms, host immune interactions, diagnostic approaches, and current control measures, with emphasis on recent genomic, proteomic, and transcriptomic advances.
Etiology and Taxonomy
Renibacterium salmoninarum is the sole species within the genus Renibacterium, belonging to the family Micrococcaceae within the phylum Actinobacteria [1]. The organism is a non-motile, non-spore-forming, Gram-positive coccobacillus (0.3–1.0 μm in diameter), often occurring in pairs or short chains [1]. Its growth is extremely slow, requiring specialized media such as KDM2 (Kidney Disease Medium 2) or selective charcoal agar, with colonies typically visible only after 2–6 weeks of incubation at 15–18 °C [1]. The bacterium is catalase-positive and oxidase-negative, and its cell wall contains unusual lipids, including high levels of branched-chain fatty acids, which contribute to its hydrophobicity and adherence properties [1].
Genome and Pan-Genomic Diversity
Whole-genome sequencing has revealed considerable genetic diversity among R. salmoninarum isolates. A novel lineage was identified in the North-East Atlantic, suggesting geographic endemism combined with anthropogenic spread through fish movements and trade [2]. Comparative pan-genomic analysis of 51 isolates demonstrated heterogeneity in the principal virulence factor, the 57 kDa protein (p57), with evidence of phase variation and gene content differences among lineages [5]. Lineage typing methods have been developed for epidemiological surveillance, particularly in Chilean salmon farms where distinct epidemic clones circulate [6]. The genome is characterized by a high GC content (approximately 56%) and a relatively small size (about 3.1 Mb), with a reduced number of metabolic pathways consistent with its intracellular lifestyle [2, 5].
Virulence Factors
The most extensively characterized virulence determinant is the 57 kDa soluble antigen (p57), a hydrophobic, heat-stable protein that is both secreted and associated with the cell surface [7, 1]. p57 is a major immunogen and has been shown to suppress antibody responses, inhibit phagocyte function, and promote bacterial survival within macrophages [7, 8]. Proteomic analyses indicate that p57 is overproduced under iron-limited conditions, consistent with the host environment [8]. Genomic and proteomic studies have further characterized p57 in relation to virulence patterns, showing variation in expression levels among strains [7, 5].
Extracellular membrane vesicles (MVs) have recently been identified as additional virulence factors in R. salmoninarum [9]. Proteome analysis of MVs revealed the presence of p57, other immunomodulatory proteins, and degradative enzymes that may facilitate host tissue invasion and immune evasion [9]. Cytotoxic effects of purified MVs on salmonid SHK-1 cells have been demonstrated, suggesting that vesicle-mediated delivery of virulence factors contributes to pathogenesis [10].
Pathogenesis and Host Interaction
Infection typically occurs through horizontal transmission (via water, cohabitation, or ingestion of infected material) or vertical transmission (via ovarian fluid and eggs) [11, 1]. After entry, the bacterium colonizes the gastrointestinal tract or gills, then disseminates hematogenously to the kidney and spleen [4]. R. salmoninarum is a facultative intracellular pathogen that survives and replicates within macrophages, exploiting the host cell's phagolysosomal compartment [1].
Transcriptomic profiling of the host response has illuminated the molecular basis of pathogenesis. In Atlantic salmon (Salmo salar), infection induces a robust innate immune response characterized by upregulation of interferon-related genes and pro-inflammatory cytokines [12]. However, the cell-mediated adaptive immune response is often inhibited, particularly in surviving pre-smolts, leading to a higher risk of mortality during later stages at lower water temperatures [30]. In lumpfish (Cyclopterus lumpus), head kidney transcriptome analysis revealed distinct expression patterns at early versus chronic infection stages, with cell-mediated immunity becoming more prominent in the chronic phase [13, 14]. The involvement of pattern recognition receptors such as DDX41 has been characterized, with the ddx41 gene showing evolutionary conservation and differential expression following R. salmoninarum exposure in Atlantic salmon [15].
Histological progression studies in Chinook salmon (Oncorhynchus tshawytscha) have correlated bacterial load with the severity of granulomatous inflammation in kidney and spleen tissues [4]. The disease typically follows a chronic course, with affected fish exhibiting exophthalmia, abdominal distension due to ascites, and pale, swollen kidneys with distinct granulomas [4, 1].
Transmission
Horizontal transmission is the primary route in aquaculture settings, where high stocking densities facilitate waterborne spread [2, 16]. Cohabitation experiments in rainbow trout (Oncorhynchus mykiss) have shown that injection and immersion challenges can both establish infection, although injection routes yield more consistent results [17]. Vertical transmission has been definitively demonstrated in cutthroat trout (Oncorhynchus clarkii), where the bacterium is present in ovarian fluid and can be transmitted to progeny [11]. Non-lethal sampling studies indicate that the pathogen can be detected in mucus, blood, and ovarian fluid, which may serve as sources for both vertical and horizontal transmission [18, 19].
Epidemiology and Geographic Distribution
R. salmoninarum has a global distribution, with significant impacts in North America, Europe, South America, and Asia [2, 3, 1]. In Chile, the world's second-largest salmon producer, BKD is endemic and causes substantial losses in Atlantic salmon and rainbow trout farming; lineage typing has identified epidemic strains in this region [6]. In Sweden, a study assessing the presence of the bacterium in both farmed and wild fish found evidence of spread between the two populations, underscoring the role of aquaculture as a reservoir [16]. In Colorado, USA, the prevalence and distribution of R. salmoninarum in wild trout fisheries were documented, with infection rates varying by species and geographical location [20]. The first report of BKD in chum salmon (Oncorhynchus keta) farmed in South Korea expanded the known host range in Asia [3]. In Russia, BKD was reported in coho salmon (Oncorhynchus kisutch), further confirming the pathogen's presence across the North Pacific Rim [32]. Low-level infection has also been detected in wild brown trout (Salmo trutta fario) in Austrian rivers [34]. Serological surveys in Lake Michigan, USA, have revealed high prevalence of circulating antibodies to R. salmoninarum in spawning Oncorhynchus spp., indicating widespread exposure in wild populations [21].
Clinical Signs and Pathology
Clinical signs of BKD are most commonly observed in juvenile to adult salmonids and include exophthalmia, abdominal distension, pale gills, and darkening of the skin [4, 1]. Internally, the kidney is characteristically enlarged, pale, and shows granulomatous lesions; the spleen may also be affected [4]. Histologically, granulomas are composed of epithelioid macrophages and multinucleated giant cells, with intracellular bacterial clusters visible with Gram staining [4]. The disease course can be chronic, with mortality occurring over weeks to months, particularly under stress conditions such as high rearing density, poor nutrition, or elevated water temperature [33].
Diagnostic Methods
A range of diagnostic techniques are available, each with specific applications and limitations. Culture isolation remains the gold standard but is hampered by the bacterium's slow growth and the need for specialized media [1]. Molecular detection by quantitative PCR (qPCR) targeting the p57 gene or the 16S rRNA gene is the most sensitive and widely used method for diagnosis and surveillance [18, 22, 19]. Non-lethal sampling approaches using mucus swabs, blood, or ovarian fluid have been validated for qPCR detection, reducing the need for sacrifice of valuable broodstock [18, 19, 23].
Recent advances include isothermal recombinase polymerase amplification (RPA) combined with CRISPR-Cas12a detection, which enables rapid field diagnostics suitable for environmental DNA (eDNA) samples [24]. This method offers sensitivity comparable to qPCR with shorter turnaround times for low-resource settings. Enzyme-linked immunosorbent assays (ELISAs) for detection of p57 antigen in kidney tissue or fluid are also used, particularly for screening large numbers of fish [25, 26]. Additionally, single-stranded DNA aptamers targeting p57 have been developed as alternatives to antibodies for diagnostic capture [26].
Bayesian latent class models have been employed to estimate infection status across multiple tissue types and assays, allowing for improved diagnostic accuracy when imperfect reference standards are used [22]. Comparative studies have evaluated the performance of qPCR, culture, and ELISA on various sample types (kidney, mucus, blood, ovarian fluid) in harvested Atlantic salmon, providing guidance for cost-effective surveillance programs [25].
flowchart TD
A[Fish population sampling], > B{Clinical signs present?}
B, >|Yes| C[Select symptomatic fish]
B, >|No| D[Sample kidney, mucus, or blood]
C, > E[Perform qPCR on kidney tissue]
D, > E
E, > F{Positive for R. salmoninarum?}
F, >|Yes| G[Confirm with culture or nested PCR]
F, >|No| H[Consider other causes, e.g., Aeromonas, Yersinia]
G, > I[Determine lineage if needed using MLST]
I, > J[Implement control measures]
H, > K[Further differential diagnostics]
The Mermaid diagram above outlines a diagnostic decision tree for BKD detection, emphasizing qPCR as the primary screening tool followed by confirmatory culture or lineage typing for epidemiological purposes.
Therapeutic and Control Strategies
Management of BKD is challenging due to the intracellular nature of the pathogen and the lack of effective vaccines. Antimicrobial therapy with erythromycin has historically been used, both as intraperitoneal injections in broodstock to reduce vertical transmission and as oral feed treatments [31]. However, emergence of resistance and variable efficacy have prompted development of standardized minimum inhibitory concentration (MIC) testing protocols for R. salmoninarum in Chilean salmon farms [27]. The proposed protocol uses a broth microdilution method in Cation-Adjusted Mueller-Hinton broth supplemented with 2% NaCl and 1% L-lysine, with incubation at 15 °C for 7–15 days [27].
Vaccine development remains an active area of research. In silico design of a multiantigenic and multiepitope chimeric protein as a vaccine candidate has been reported [28], integrating epitopes from p57 and other conserved antigens. Nutritional immunomodulation strategies, such as supplementation with immunostimulatory compounds (e.g., β-glucans, nucleotides), have been evaluated for their ability to enhance Atlantic salmon response to R. salmoninarum bacterin [29]. Transcriptomic analysis of head kidney from salmon injected with formalin-killed R. salmoninarum revealed that nutritional intervention can modulate the expression of immune-related genes, potentially improving vaccine efficacy [35]. However, no commercial vaccine is currently available, and control relies on biosecurity, early detection, and culling of infected stock.
FAQ
What is bacterial kidney disease (BKD)?
Bacterial kidney disease is a chronic, systemic granulomatous infection of salmonid fish caused by the Gram-positive intracellular bacterium Renibacterium salmoninarum [1]. It is characterized by progressive inflammation of the kidney and hematopoietic tissues, leading to high mortality in both farmed and wild salmonid populations [4, 3].
How is Renibacterium salmoninarum transmitted?
Transmission occurs both horizontally, via waterborne routes, cohabitation, and ingestion of infected material, and vertically, through infected ovarian fluid and eggs from broodstock [11, 16, 1]. The bacterium can survive for prolonged periods in the aquatic environment, facilitating spread within and between populations [2].
What are the clinical signs of BKD in salmonids?
Affected fish typically exhibit exophthalmia, abdominal distension due to ascites, pale gills, and darkening of the skin [4, 1]. Internally, the kidney and spleen are swollen and contain characteristic granulomas [4]. The disease follows a chronic course, with mortality occurring over weeks to months, especially under stress [33].
How is BKD diagnosed in fish?
Diagnosis is most reliably performed by qPCR targeting the p57 or 16S rRNA genes on kidney, mucus, blood, or ovarian fluid samples [18, 22, 19]. Culture on KDM2 agar remains the gold standard but is slow [1]. Alternative methods include antigen detection ELISA, RPA-CRISPR assays for field use, and serological detection of antibodies [24, 25, 26, 21].
What treatment options exist for BKD?
Antimicrobial therapy with erythromycin (intraperitoneal injection or oral feed) has been used to reduce vertical transmission and treat infections, but efficacy is variable and resistance has been reported [27, 31]. Standardized MIC testing protocols have been proposed to guide antimicrobial selection [27]. No fully effective vaccine is yet available, although multi-epitope chimeric protein vaccines are under development [28].
Is there a vaccine against Renibacterium salmoninarum?
No commercial vaccine is currently licensed for BKD [1]. However, experimental efforts include in silico designed multiantigenic proteins [28], bacterin-based vaccines combined with nutritional immunomodulation [29, 35], and studies on lumpfish susceptibility that may inform future vaccine development for cleaner fish species [14].
What are the major virulence factors of R. salmoninarum?
The 57 kDa surface protein (p57) is the major virulence factor, acting as an adhesin and immunomodulator that suppresses host immune responses [7, 8]. Additionally, extracellular membrane vesicles containing p57 and other effectors contribute to tissue damage and immune evasion [9, 10]. Genomic variation in p57 among lineages may affect virulence potential [5].
How does the host immune system respond to R. salmoninarum?
The innate immune response involves upregulation of interferon pathways and pro-inflammatory cytokines [12]. However, infected fish often exhibit inhibition of cell-mediated adaptive immunity, particularly during chronic infection [30]. Transcriptomic profiling in Atlantic salmon and lumpfish has identified distinct early and chronic stage responses, including roles for DDX41 and cellular immune pathways [15, 13, 14].
Can BKD be detected using non-lethal sampling methods?
Yes, non-lethal sampling of mucus swabs, blood, or ovarian fluid combined with qPCR provides sensitive detection without sacrificing fish [18, 19, 23]. This is especially useful for broodstock screening and monitoring of threatened wild populations [18, 22].
What is the geographic distribution of R. salmoninarum?
The bacterium is found in salmonid populations worldwide, including North America, Europe, South America (Chile), Russia, and Asia (South Korea) [2, 3, 20, 16, 32, 34]. Lineage typing and genomic epidemiology have revealed both endemic strains and evidence of anthropogenic spread [2, 6].
References
[1] Delghandi MR, El-Matbouli M, Menanteau-Ledouble S. Renibacterium salmoninarum-The Causative Agent of Bacterial Kidney Disease in Salmonid Fish. Pathogens. 2020. https://pubmed.ncbi.nlm.nih.gov/33076564/
[2] Villamil-Alonso A, Moldal T, Bøe CA, et al. Whole-genome sequencing reveals a novel Renibacterium salmoninarum lineage and suggests geographic endemism combined with anthropogenic spread in the North-East Atlantic Area. Appl Environ Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42165807/
[3] Kong KH, Gong IH, Jung SJ, et al. First Report of Bacterial Kidney Disease (BKD) Caused by Renibacterium salmoninarum in Chum Salmon (Oncorhynchus keta) Farmed in South Korea. Microorganisms. 2024. https://pubmed.ncbi.nlm.nih.gov/39597718/
[4] Dils RE, Firestone TBR, Schaffer PA, et al. Histological progression and bacterial load dynamics of Renibacterium salmoninarum in Chinook salmon Oncorhynchus tshawytscha. Dis Aquat Organ. 2025. https://pubmed.ncbi.nlm.nih.gov/40401534/
[5] Saldarriaga-Córdoba M, Avendaño-Herrera R. Comparative pan-genomic analysis of 51 Renibacterium salmoninarum indicates heterogeneity in the principal virulence factor, the 57 kDa protein. J Fish Dis. 2022. https://pubmed.ncbi.nlm.nih.gov/35604683/
[6] Mora-Salas P, Zapararte S, Villouta P, et al. Method for lineage typing of epidemic Renibacterium salmoninarum in Chilean salmon farms. J Fish Dis. 2023. https://pubmed.ncbi.nlm.nih.gov/36696457/
[7] Aguilar M, Isla A, Barrientos CA, et al. Genomic and proteomic aspects of p57 protein from Renibacterium salmoninarum: Characteristics in virulence patterns. Microb Pathog. 2023. https://pubmed.ncbi.nlm.nih.gov/36473669/
[8] Avendaño-Herrera R, Saldivia P, Bethke J, et al. Proteomic analysis reveals Renibacterium salmoninarum grown under iron-limited conditions induces iron uptake mechanisms and overproduction of the 57-kDa protein. J Fish Dis. 2022. https://pubmed.ncbi.nlm.nih.gov/34791674/
[9] Kroniger T, Flender D, Schlüter R, et al. Proteome analysis of the Gram-positive fish pathogen Renibacterium salmoninarum reveals putative role of membrane vesicles in virulence. Sci Rep. 2022. https://pubmed.ncbi.nlm.nih.gov/35194033/
[10] Echeverría-Bugueño M, Balada C, Irgang R, et al. Evidence for the existence of extracellular vesicles in Renibacterium salmoninarum and related cytotoxic effects on SHK-1 cells. J Fish Dis. 2021. https://pubmed.ncbi.nlm.nih.gov/33683739/
[11] Riepe TB, Fetherman ER, Neuschwanger B, et al. Vertical transmission of Renibacterium salmoninarum in cutthroat trout (Oncorhynchus clarkii). J Fish Dis. 2023. https://pubmed.ncbi.nlm.nih.gov/36606373/
[12] Eslamloo K, Caballero-Solares A, Inkpen SM, et al. Transcriptomic Profiling of the Adaptive and Innate Immune Responses of Atlantic Salmon to Renibacterium salmoninarum Infection. Front Immunol. 2020. https://pubmed.ncbi.nlm.nih.gov/33193341/
[13] Gnanagobal H, Chakraborty S, Vasquez I, et al. Transcriptome profiling of lumpfish (Cyclopterus lumpus) head kidney to Renibacterium salmoninarum at early and chronic infection stages. Dev Comp Immunol. 2024. https://pubmed.ncbi.nlm.nih.gov/38499166/
[14] Gnanagobal H, Cao T, Hossain A, et al. Lumpfish (Cyclopterus lumpus) Is Susceptible to Renibacterium salmoninarum Infection and Induces Cell-Mediated Immunity in the Chronic Stage. Front Immunol. 2021. https://pubmed.ncbi.nlm.nih.gov/34880856/
[15] Yañez AJ, Barrientos CA, Isla A, et al. Discovery and Characterization of the ddx41 Gene in Atlantic Salmon: Evolutionary Implications, Structural Functions, and Innate Immune Responses to Piscirickettsia salmonis and Renibacterium salmoninarum Infections. Int J Mol Sci. 2024. https://pubmed.ncbi.nlm.nih.gov/38928053/
[16] Persson BD, Aspán A, Hysing P, et al. Assessing the presence and spread of Renibacterium salmoninarum between farmed and wild fish in Sweden. J Fish Dis. 2022. https://pubmed.ncbi.nlm.nih.gov/35092707/
[17] Watson TR, Bruce TJ, Ma J, et al. Comparison of injection and immersion challenges of Renibacterium salmoninarum strains in Rainbow Trout. J Aquat Anim Health. 2023. https://pubmed.ncbi.nlm.nih.gov/36367349/
[18] Firestone TBR, Fetherman ER, Winkelman DL. Nonlethal detection of Renibacterium salmoninarum in Greenback Cutthroat Trout Oncorhynchus clarkii stomias comparing mucus, blood, and ovarian fluid samples to kidney tissues. J Aquat Anim Health. 2025. https://pubmed.ncbi.nlm.nih.gov/40924024/
[19] Jansson E, Aspán A, Comin A, et al. Non-lethal sampling for the detection of Renibacterium salmoninarum by qPCR for diagnosis of bacterial kidney disease. J Fish Dis. 2022. https://pubmed.ncbi.nlm.nih.gov/35363399/
[20] Kowalski DA, Cordes RJ, Riepe TB, et al. Prevalence and distribution of Renibacterium salmoninarum, causative agent of bacterial kidney disease, in wild trout fisheries in Colorado. Dis Aquat Organ. 2022. https://pubmed.ncbi.nlm.nih.gov/35678356/
[21] Richards CA, Abdel-Latif HMR, Loch TP, et al. HIGH PREVALENCE OF CIRCULATING ANTIBODIES TO RENIBACTERIUM SALMONINARUM IN SPAWNING ONCORHYNCHUS SPP. FROM LAKE MICHIGAN, USA. J Wildl Dis. 2021. https://pubmed.ncbi.nlm.nih.gov/33635967/
[22] Firestone TBR, Fetherman ER, Huyvaert KP, et al. Leveraging detection uncertainty to estimate Renibacterium salmoninarum infection status among multiple tissues and assays. PLoS One. 2025. https://pubmed.ncbi.nlm.nih.gov/40338968/
[23] Riepe TB, Vincent V, Milano V, et al. Evidence for the Use of Mucus Swabs to Detect Renibacterium salmoninarum in Brook Trout. Pathogens. 2021. https://pubmed.ncbi.nlm.nih.gov/33921208/
[24] D'Agnese E, Chase D, Andruszkiewicz-Allan E. ISOTHERMAL RECOMBINANT POLYMERASE AMPLIFICATION AND CRIPSR(CAS12A) ASSAY DETECTION OF RENIBACTERIUM SALMONINARUM AS AN EXAMPLE FOR WILDLIFE PATHOGEN DETECTION IN ENVIRONMENTAL DNA SAMPLES. J Wildl Dis. 2023. https://pubmed.ncbi.nlm.nih.gov/37791744/
[25] Jia B, Burnley H, Gardner IA, et al. Diagnosis of Renibacterium salmoninarum infection in harvested Atlantic salmon (Salmo salar L.) on the east coast of Canada: Clinical findings, sample collection methods and laboratory diagnostic tests. J Fish Dis. 2023. https://pubmed.ncbi.nlm.nih.gov/36861304/
[26] Layman B, Mandella B, Carter J, et al. Isolation and Characterization of a ssDNA Aptamer against Major Soluble Antigen of Renibacterium salmoninarum. Molecules. 2022. https://pubmed.ncbi.nlm.nih.gov/35335217/
[28] Araneda J, Flores-Herrera PA, Acevedo W, et al. In silico design of a multiantigenic and multiepitope chimeric protein as a vaccine candidate against Renibacterium salmoninarum. Front Cell Infect Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42328174/
[29] Emam M, Eslamloo K, Caballero-Solares A, et al. Nutritional immunomodulation of Atlantic salmon response to Renibacterium salmoninarum bacterin. Front Mol Biosci. 2022. https://pubmed.ncbi.nlm.nih.gov/36213116/